CRA Insights: Intellectual Property is a periodic newsletter that provides summaries of notable developments in IP litigation.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...